Risk of false positive results to SARM S-4 in case of therapeutic use of antineoplastic/antiandrogen drug containing flutamide: a case study

Risk of false positive results to SARM S-4 in case of therapeutic use of antineoplastic/antiandrogen drug containing flutamide : a case study / L. Perrenoud, C. Schweizer Grundisch, N. Baume, Martial Saugy, Raul Nicoli. - (Drug Testing and Analysis 8 (2016) 11-12 (November-December); p. 1109-1113)

  • PMID: 27511110
  • DOI: 10.1002/dta.2051

Parameters

Science
Case report
Date
10 August 2016
People
Baume, Norbert
Nicoli, Raul
Perrenoud, L.
Saugy, Martial
Schweizer Grundisch, C.
Country
Switzerland
Language
English
Other organisations
Lausanne Laboratory for doping analysis
University of Lausanne
Laboratories
Lausanne, Switzerland: Laboratoire Suisse d’Analyse du Dopage
Analytical aspects
False Positive
Reliability of the testing method / testing result
Testing method development
Doping classes
S1. Anabolic Agents
Substances
Selective androgen receptor modulators (SARMs)
Medical terms
Legitimate Medical Treatment
Document category
Abstract
Date generated
23 September 2020
Date of last modification
24 September 2020
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin